Photodynamic Therapy in Dermatology – an Update 2008

Photodynamic therapy (PDT) is used for the prevention and treatment of non‐melanoma skin cancer. Until recently, clinically approved indications have been restricted to actinic keratoses, nodular and superficial basal cell carcinoma, and – since 2006 – Bowen disease. However, the range of indications has been expanding continuously. PDT is also used for the treatment of non‐malignant conditions such as acne vulgaris and leishmaniasis, as well as for treating premature skin aging due to sun exposure. Here, PDT is used for the stimulation of immunomodulatory effects in contrast to the induction of necrosis and apoptosis as produced in the treatment of skin tumors. The porphyrin precursor 5‐aminolevulinic acid (ALA) or its methyl ester (MAL, so far the only approved formulation in Europe) is applied topically as photosensitizer to exclude systemic reactions. Possible light sources include lasers as well as incoherent light sources; irradiation with incoherent light sources is cheaper and more appropriate for large treatment areas. The main advantages of PDT in comparison to other treatment modalities are its excellent cosmetic results and its high remission rates despite low invasiveness.This article provides up‐to‐date information about PDT with focus on recently published studies.

[1]  H. Gu,et al.  Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata, a randomized clinical trial , 2007, The British journal of dermatology.

[2]  H. Wulf,et al.  Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial , 2006, The British journal of dermatology.

[3]  A. Wennberg,et al.  Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study , 2006, The British journal of dermatology.

[4]  F. Moloney,et al.  Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.

[5]  M. Davami,et al.  Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo‐controlled, randomized clinical trial , 2006, Clinical and experimental dermatology.

[6]  M. Gold,et al.  Split‐Face Comparison of Photodynamic Therapy with 5‐Aminolevulinic Acid and Intense Pulsed Light Versus Intense Pulsed Light Alone for Photodamage , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  A. Bosserhoff,et al.  Keratinocyte‐derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts , 2004, The British journal of dermatology.

[8]  J. Ring,et al.  Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. , 2006, Journal of drugs in dermatology : JDD.

[9]  D I McLean,et al.  Oral Aminolevulinic Acid Induces Protoporphyrin IX Fluorescence in Psoriatic Plaques and Peripheral Blood Cells†,¶ , 2001, Photochemistry and photobiology.

[10]  P. Bjerring,et al.  5‐ALA for photodynamic photorejuvenation—optimization of treatment regime based on normal‐skin fluorescence measurements , 2007, Lasers in surgery and medicine.

[11]  M. Beck,et al.  Allergic contact dermatitis to methyl aminolevulinate (Metvix®) cream used in photodynamic therapy , 2007, Photodermatology, photoimmunology & photomedicine.

[12]  C. Jaffe,et al.  Treatment of cutaneous leishmaniasis with photodynamic therapy. , 2003, Archives of dermatology.

[13]  R. Szeimies,et al.  Photodynamische Therapie nichtonkologischer Indikationen , 2007, Der Hautarzt.

[14]  M. Venturini,et al.  Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin , 2007, Lasers in surgery and medicine.

[15]  M. Landthaler,et al.  Disappointing results and low tolerability of photodynamic therapy with topical 5‐aminolaevulinic acid in psoriasis. A randomized, double‐blind phase I/II study , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  H. Wulf,et al.  Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. , 2006, Acta dermato-venereologica.

[17]  Henricus J C M Sterenborg,et al.  Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. , 2006, The Journal of investigative dermatology.

[18]  I. Whitaker,et al.  Combined CO(2) laser with photodynamic therapy for the treatment of nodular basal cell carcinomas. , 2007, Annals of Plastic Surgery.

[19]  Carola Berking,et al.  Effect of Subcutaneous Infiltration Anesthesia on Pain in Photodynamic Therapy: A Controlled Open Pilot Trial , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  I. Stojiljković,et al.  Antimicrobial properties of porphyrins , 2001, Expert opinion on investigational drugs.

[21]  S. Ibbotson,et al.  A randomized, double‐blind, placebo‐controlled study of the efficacy of tetracaine gel (Ametop®) for pain relief during topical photodynamic therapy , 2004, The British journal of dermatology.

[22]  R. Sala,et al.  Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T‐cell lymphoma , 2006, Photodermatology, photoimmunology & photomedicine.

[23]  M. Landthaler,et al.  In vitro and in vivo comparison of two different light sources for topical photodynamic therapy , 2006, The British journal of dermatology.

[24]  P. Wolf,et al.  Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. , 2006, Archives of dermatology.

[25]  Menno A de Rie,et al.  Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.

[26]  Petras Juzenas,et al.  Topical Application of 5-Aminolevulinic Acid and its Methylester, Hexylester and Octylester Derivatives: Considerations for Dosimetry in Mouse Skin Model¶ , 2002, Photochemistry and photobiology.

[27]  K. Andersen,et al.  Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients , 2007, Contact dermatitis.

[28]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[29]  P. von den Driesch,et al.  Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. , 2004, Journal of the American Academy of Dermatology.

[30]  E. Tschen,et al.  Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12‐month follow up , 2006, The British journal of dermatology.

[31]  Carin Sandberg,et al.  Important factors for pain during photodynamic therapy for actinic keratosis. , 2006, Acta dermato-venereologica.

[32]  M. Poljački,et al.  Topical photodynamic therapy , 2006 .

[33]  M. Alexiades-Armenakas.  Laser-mediated photodynamic therapy. , 2006, Clinics in dermatology.

[34]  P. Lehmann.  Methyl aminolaevulinate–photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer , 2007, The British journal of dermatology.

[35]  L. Kemény,et al.  Skin cancers after organ transplantation. , 2003, The New England journal of medicine.

[36]  Ann-Marie Wennberg,et al.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.

[37]  J. Dover,et al.  Photodynamic therapy for cosmetic applications , 2005, Dermatologic therapy.

[38]  M. Landthaler,et al.  Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. , 2007, The British journal of dermatology.

[39]  G. Stables,et al.  The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. , 1996, The Journal of investigative dermatology.

[40]  M. Murison,et al.  Combined CO2 Laser With Photodynamic Therapy for the Treatment of Nodular Basal Cell Carcinomas , 2007 .

[41]  P. Karran,et al.  Treatment of post‐transplant premalignant skin disease: a randomized intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy , 2007, The British journal of dermatology.

[42]  N. Pimpinelli,et al.  Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. , 2006, Journal of the American Academy of Dermatology.

[43]  T. Horio,et al.  Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid , 2007, The Journal of dermatology.

[44]  Cynthia C. Morton,et al.  Intraindividual, right–left comparison of topical methyl aminolaevulinate‐photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study , 2006, The British journal of dermatology.

[45]  P. Collins,et al.  Randomized, double‐blind, placebo‐controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5‐aminolaevulinic acid–photodynamic therapy for extensive scalp actinic keratoses , 2006, The British journal of dermatology.

[46]  C. Morton,et al.  Topical 5‐ALA photodynamic therapy for the treatment of cutaneous T‐cell lymphoma , 2002, Clinical and experimental dermatology.

[47]  C. Jaffe,et al.  Treatment of cutaneous leishmaniasis with photodynamic therapy. , 2003, Archives of dermatology.

[48]  Prapawan Choawawanich.  Treatment of Inflammatory Facial Acne Vulgaris with Intense Pulsed Light and Short Contact of Topical 5‐Aminolevulinic Acid: A Pilot Study , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[49]  C. Berking,et al.  The Efficacy of Photodynamic Therapy in Actinic Cheilitis of the Lower Lip: A Prospective Study of 15 Patients , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].